The phrase "a therapy that improves" is correct and usable in written English.
You can use it when describing a type of therapy that has beneficial effects or enhances a particular condition or situation.
Example: "The study focused on a therapy that improves cognitive function in patients with memory disorders."
Alternatives: "a treatment that enhances" or "an intervention that boosts".
A therapy that improves survival would not directly reduce transmission, though it would have immense humanitarian value.
A therapy that improves chemotherapy adherence by reducing CINV events could potentially reduce costs, both direct (costs of antiemetic medications, physician visits, and hospitalizations) and indirect (lost workdays and intangibles, including lower quality of life and potential consequences of delayed or reduced chemotherapy treatment).
Our results reveal, for the first time, in vivo efficacy and safety of a molecular therapy that improves downstream metabolic defects in TK2 deficiency.
Moderate dietary restriction has long been recognised as a natural therapy that improves health, promotes longevity, and reduces both the incidence and growth of many tumour types.
Dietary caloric restriction (DR) has long been recognised as a natural therapy that improves health, promotes longevity, and significantly reduces the incidence, establishment, and growth of many tumour types (Rous, 1914; Tannenbaum, 1959; Weindruch and Walford, 1988; Birt et al, 1999; Kritchevsky, 1999a; Duan et al, 2003; Koubova and Guarente, 2003).
Dietary restriction (DR) has long been recognised as a natural therapy that improves health, promotes longevity, and significantly reduces both the incidence and growth of many tumour types (Rous, 1914; Tannenbaum, 1959; Weindruch and Walford, 1988; Birt et al, 1999; Kritchevsky, 1999b).
Alzheimer's disease remains without a disease-modifying therapy that improves symptoms after therapy withdrawal.
Our data show that using the AposTherapy system and treatment methodology is an effective non-pharmacological therapy that improves both pain and function in patients with knee OA.
This patient group would greatly benefit from therapy that improves cardiac function.
There are few parameters that will accurately predict rate of decline at the time of diagnosis and the only therapy that improves survival is lung transplantation in eligible candidates.
Such models are the standard tools to evaluate disease-modifying OA drugs, and have been used to identify a large number of therapies that improve experimental lesions.
